
Interstitial Viable Ectopic Pregnancy Managed with Systemic Methotrexate
Author(s) -
Ibrahim Hegazy
Publication year - 2022
Language(s) - English
DOI - 10.47363/jgrrr/2022(4)148
Subject(s) - ectopic pregnancy , medicine , methotrexate , miscarriage , obstetrics , human chorionic gonadotropin , vaginal bleeding , pregnancy , salpingostomy , medical history , products of conception , gynecology , abortion , surgery , hormone , genetics , biology
A 29-year-old woman, 6weeks and 3 days pregnant as assessed by her last menstrual period, presented to our emergency department with vaginal bleeding and pelvic pain for 4 days. She was a gravida 3 para 0 with a history of ectopic on her first pregnancy in the left tube managed by salpingostomy, her second pregnancy was unfortunately a miscarriage at 7 wks managed by medical management and ERPC. At the time of diagnosis, she had a left interstitial ectopic pregnancy with serum B human chorionic gonadotropin (β-HCG) was 20094 mIU / mL. The ectopic pregnancy was managed by intramuscular methotrexate.